Huntleigh Advisors’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-263,231
Closed -$1.18M – 302
2026
Q2
$1.18M Buy
263,231
+17,311
+7% +$68.6K 0.17% 131
2026
Q1
$907K Buy
245,920
+9,522
+4% +$35.6K 0.16% 128
2025
Q4
$827K Buy
+236,398
New +$824K 0.14% 132

Other funds holding APYX

Huntleigh Advisors's APYX Position: Q3 2026 in Review

Huntleigh Advisors sold out of Apyx Medical (APYX) in Q3 2026, closing a stake of 263,231 shares — an estimated $1.18M sold.

Huntleigh Advisors first reported a position in APYX in Q4 2025 and held it in 3 quarters. The position peaked at $1.18M in Q2 2026. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2026.

  • Huntleigh Advisors reported no remaining Apyx Medical position as of Q3 2026 after selling out during the quarter.
  • Huntleigh Advisors sold 263,231 Apyx Medical shares in Q3 2026, an estimated $1.18M.
  • Huntleigh Advisors first reported a position in Apyx Medical in Q4 2025 and held it in 3 quarters.
  • Huntleigh Advisors's Apyx Medical position peaked at $1.18M in Q2 2026.
  • 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.

Based on Huntleigh Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.